Bon announces revolutionary postbiotic blood sugar solution nears patent launch

Xi'an, china, march 20, 2025 (globe newswire) -- bon natural life limited (nasdaq: bon) ("bon" or the "company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced a game-changing patent for a natural postbiotic ingredient designed to regulate blood sugar is gearing up for release. the company has engineered a food-derived postbiotic formula for glycemic management, slated to hit shelves in the near term.
BON Ratings Summary
BON Quant Ranking